Search for: "WATSON PHARMACEUTICALS, INC." Results 41 - 60 of 225
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Mar 2014, 11:03 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited (these three companies are, collectively, "Mylan"); Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE;… [read post]
2 Mar 2014, 8:47 pm by Patent Docs
Watson Laboratories Inc. et al. 1:14-cv-00268; filed February 27, 2014 in the District Court of Delaware • Plaintiff: Takeda Pharmaceuticals USA Inc. [read post]
26 Feb 2014, 5:37 pm
  Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
6 Feb 2014, 6:31 am by RatnerPrestia
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993), and need not find facts when evidence is disputed in these cases.[10] In 2005, the Federal Circuit sat en banc in Phillips. [read post]
27 Nov 2013, 6:00 am
Actavis, Inc., along with its wholly owned subsidiaries Actavis Pharma and Watson Laboratories, (collectively, "Actavis") are pharmaceutical companies that develop, manufacture, market and distribute generic pharmaceutical products for sale in the United States. [read post]
15 Sep 2013, 9:42 pm by Patent Docs
• Defendant: Watson Laboratories Inc. [read post]
16 Jun 2013, 9:32 pm by Patent Docs
Watson Laboratories Inc. et al. 1:13-cv-01015; filed June 6, 2013 in the District Court of Delaware • Plaintiff: Fresenius Kabi USA, LLC • Defendants: Watson Laboratories Inc.; Actavis Inc. [read post]
10 Jun 2013, 9:30 pm by Alix McKenna
Watson Pharmaceuticals, Inc, a case raising the question of the legality of these agreements. [read post]
11 Apr 2013, 4:57 am by Eric Guttag
FTC Sues Regarding AndroGel Patent SettlementThe Federal Trade Commission has filed a complaint in federal district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. to delay generic competition to Solvay’s branded testosterone-replacement drug AndroGel, a prescription pharmaceutical with annual sales of more than… [read post]